VQV Signal
Drug discovery costs have doubled every nine years since the 1950s, with new drugs taking 10-15 years to develop. AI is being leveraged to address these challenges by closing the data loop in the drug development process.
Drug discovery costs have doubled every nine years since the 1950s, with new drugs taking 10-15 years to develop. AI is being leveraged to address these challenges by closing the data loop in the drug development process.
AI-assisted summary based on the listed source.
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market...
Reducing time and cost in drug discovery could accelerate bringing new pharmaceuticals to market, offering a competitive edge in a high-risk industry. AI's role in managing and utilizing data more effectively may help overcome longstanding inefficiencies.
VQV organizes public signals from inspectable sources. It does not independently verify the underlying report.
Signal Strength reflects source quality, relevance, freshness and evidence. Public Interest helps organize discovery; it is not proof of truth.
VQV surfaced this signal because it is recent, relevant to AI Search, connected to MIT Technology Review AI.
No login, cookies, social SDKs, or automatic posting.